Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -24.31x is 63% above its 3-year average of -65.35x, near the high end of its 3-year range (-188.88x–-19.84x).
As of the fiscal period ended Monday, December 31, 2018. 45.65% above its 12-month average of -44.73x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2018 (2018-12-31): -24.31x.
INTEREST COVERAGE RATIO
-24.31x
INTEREST COVERAGE RATIO AVG TTM
-44.73x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+45.65%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
-319.88%
vs the sector median at left
Prothena Corporation plc
Market Cap
$413.59M
Interest Coverage Ratio
-24.31x
TTM Avg
-44.73x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$413.21M
Interest Coverage Ratio
-6.46x
TTM Avg
19.36x
3Y Avg
139.34x
5Y Avg
245.68x
Market Cap
$410.92M
Interest Coverage Ratio
-404.95x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$410.57M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$409.89M
Interest Coverage Ratio
-375.67x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$409.28M
Interest Coverage Ratio
-20641.60x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$419.40M
Interest Coverage Ratio
-13.80x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$406.54M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Prothena Corporation plc (PRTA) | $413.59M | -24.31x | -44.73x | N/A | N/A |
| Myriad Genetics, Inc. (MYGN)vs › | $413.21M | -6.46x | 19.36x | 139.34x | 245.68x |
| Rezolute, Inc. (RZLT)vs › | $415.14M | N/A | N/A | N/A | N/A |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $410.92M | -404.95x | N/A | N/A | N/A |
| Strata Critical Medical, Inc. (SRTA)vs › | $410.57M | N/A | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $409.89M | -375.67x | N/A | N/A | N/A |
| Neurogene Inc. (NGNE)vs › | $409.28M | -20641.60x | N/A | N/A | N/A |
| Senseonics Holdings, Inc. (SENS)vs › | $419.40M | -13.80x | N/A | N/A | N/A |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $406.54M | N/A | N/A | N/A | N/A |
| Carlsmed, Inc. (CARL)vs › | $403.97M | -21.38x | N/A | N/A | N/A |
Interest Coverage
-24.3x
Debt/Equity
0.02
Current Ratio
25.05
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2018-12-31 | -24.31x |
| 2018-09-30 | -25.99x |
| 2018-06-30 | -68.78x |
| 2018-03-31 | -53.64x |
| 2017-12-31 | -50.93x |
| 2017-09-30 | -57.63x |
| 2017-06-30 | -19.84x |
| 2017-03-31 | -39.60x |
| 2016-09-30 | -188.88x |
| 2016-06-30 | -123.95x |
